Home Biotech Stocks Page 130

Biotech Stocks

Latest

Insys Therapeutics Presents Study Results Showing Rapid Absorption Of Epinephrine

ME Staff - February 26, 2019

Veritas Pharma Doses First Subject In Clinical Study Of CTL-X

OWC Pharmaceutical Cannabis Ointment Set To Proceed To PII After Positive PI Data

Reliq Health Technologies Expands Leadership Team As Investigations Continue

Zynerba Gives Clinical Update, Lifelong Impact Of ZYN002

Our March highlight just gained 50%: Alder Biopharmaceuticals Inc (NASDAQ:ALDR)

Roger Hannington - March 29, 2016 0

Biotech Movers and Shakers: Portola Pharmaceuticals Inc (NASDAQ:PTLA) and United Therapeutics...

Jennifer Aldershot - March 28, 2016 0

Three Biotech Updates with Catalysts: Aclaris Therapeutics Inc (NASDAQ:ACRS), Inotek Pharmaceuticals...

ME Staff - March 24, 2016 0

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

Pfizer Inc. (NYSE:PFE) Backed ArQule, Inc. (NASDAQ:ARQL) Just Gave Investors Something...

Roger Hannington - March 23, 2016 0

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) is Lining up Phase II Topline for...

- March 21, 2016 0

Orphan Drugs On a Roll, A Look Into the 2016 Orphan...

David Rich - March 21, 2016 0

Movers and Shakers: Axsome Therapeutics Inc (NASDAQ:AXSM) and Vitae Pharmaceuticals Inc...

Jennifer Aldershot - March 18, 2016 0

Halozyme Just First-Dosed in a Blockbuster Oncology Phase III

ME Staff - March 17, 2016 0

A Tough Lesson Learnt: Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Endo...

- March 16, 2016 1

Mannkind Corporation (NASDAQ:MNKD) Announces New Chief Commercial Officer

Andy Parker - March 15, 2016 0

1...129130131...146 Page 130 of 146

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 11-11-2024

November 10, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-28-2024

October 27, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-14-24

October 13, 2024

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.